Inflammtory heart diseases: etiology, pathophysiology,diagnosis and treatment (based on the recommendationsof the American and European society of cardiology)

Authors: E.Z. Golukhova, R.A. Shomakhov

Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery; Roublyevskoe shosse, 135, Moscow, 121552, Russian Federation


DOI: https://doi.org/10.15275.2015.04.06

For citation: Golukhova EZ, Shomakhov RA. Inflammtory heart diseases: etiology, pathophysiology, diagnosis and treatment (based on the recommendations of the American and European society of cardiology). Kreativnaya Kardiologiya. 2015; 4: 46-52 (in Russian)

Keywords: myocarditis heart failure heart rhythm disorders cardiac MRI

Full text:  

 

Abstract

Myocarditis is an inflammatory disease of the heart frequently resulting from viral infections and/or post-viral immune-mediated responses. In this article current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis by the European Society of Cardiology and American College of Cardiology.

References

  1. Richardson P., McKenna W., Bristow M. et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996; 93: 841–2.

  2. Kindermann I., Barth C., Mahfoud F. et al. Update on Myocarditis. JACC. 2012; 59 (9): 779–92.

  3. Gore I., Saphir O. Myocarditis; a classification of 1402 cases. Am. Heart. J. 1947; 34: 827–830.

  4. Basso C., Calabrese F., Corrado D., Thiene G. Postmortem diagnosis of sudden cardiac death victims. Cardiovasc. Res. 2001; 50: 290–300.

  5. Бокерия О. Л., Испирян А. Ю. Внезапная сердечная смерть у спортсменов. Анналы аритмологии. 2013. Т. 10. № 1. С. 31-39. DOI:10.15275/annaritmol. 2013.1.5.

  6. Mason J.W., O'Connell J.B., Herskowitz A. et al. A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 1995; 333: 269–75.

  7. Felker G.M., Hu W., Hare J.W. et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience in 1278 patients. Medicine. 1999; 78: 270–83.

  8. Towbin J.A., Lowe A.M., Colan S.D. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006; 296: 1867–76.

  9. Caforio A., Pankuweit S., Arbustini E. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2013; 34: 2636–48.

  10. Schultz J.C., Hilliard A.A., Cooper L.T. Jr., Rihal C.S. Diagnosis and treatment of viral myocarditis. Mayo Clin. Proc. 2009; 84: 1001–9.

  11. Breinholt J.P., Moulik M., Dreyer W.J. et al. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients. J. Heart Lung Transplant. 2010; 29: 739–46.

  12. Kindermann I., Kindermann M., Kandolf R. et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639–48.

  13. Pankuweit S., Moll R., Baandrup U. et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum. Pathol. 2003; 34: 497–503.

  14. Kuhl U., Pauschinger M., Schwimmbeck P.L. et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003; 107: 2793– 8.

  15. Anderson D.W., Virmani R., Reilly J.M. et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J. Am. Coll. Cardiol. 1988; 11: 792–9.

  16. Hidron A., Vogenthaler N., Santos-Preciado J.I. et al. Cardiac involvement with parasitic infections. Clin. Microbiol. Rev. 2010; 23: 324–49.

  17. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999; 99: 1091–100.

  18. Freimuth P., Philipson L., Carson S.D. The coxsackievirus and adenovirus receptor. Curr. Top. Microbiol. Immunol. 2008; 323: 67–87.

  19. Shi Y., Chen C., Lisewski U. et al. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo . J. Am. Coll. Cardiol. 2009; 53: 1219–26.

  20. Noutsias M., Fechner H., de Jonge H. et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for carcardiotropic viral infections. Circulation. 2001; 104: 275–80.

  21. Liu P.P., Mason J.W. Advances in the understanding of myocarditis. Circulation 2001; 104: 1076–82.

  22. Cooper L.T. Jr. Myocarditis. N. Engl. J. Med. 2009; 360: 1526–38.

  23. Pauschinger M., Noutsias M., Lassner D. et al. Inflammation, ECG changes and pericardial effusion: who to biopsy in suspected myocarditis? Clin. Res. Cardiol. 2006; 95: 569–83.

  24. Nakashima H., Katayama T., Ishizaki M. et al. Q wave and non-Q wave myocarditis with special reference to clinical significance. Jpn. Heart J. 1998; 39: 763–74.

  25. Ukena C., Mahfoud F., Kindermann I. et al. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur. J. Heart Fail. 2011; 13: 398–405.

  26. Blauwet L.A., Cooper L.T. Myocarditis. Prog. Cardiovasc. Dis. 2010; 52: 274–88.

  27. Felker G.M., Boehmer J.P., Hruban R.H. et al. Echocardiographic findings in fulminant and acute myocarditis. J. Am. Coll. Cardiol. 2000; 36: 227–32.

  28. Friedrich M., Sechtem U., Schulz-Menger J. et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. JACC. 2009; 53 (17): 1475–87.

  29. Baccouche H., Mahrholdt H., Meinhardt G. et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur. Heart J. 2009; 30: 2869–79.

  30. Lauer B., Niederau C., Kuhl U. et al. Cardiac troponin T in patients with clinically suspected myocarditis. J. Am. Coll. Cardiol. 1997; 30: 1354–9.

  31. Deswal A., Petersen N.J., Feldman A.M. et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001; 103: 2055–2059.

  32. Emdin M., Vittorini S., Passino C., Clerico A. Old and new biomarkers of heart failure. Eur. J. Heart Fail. 2009; 11: 331–5.

  33. Liu P., Martino T., Opavsky M.A., Penninger J. Viral myocarditis: balance between viral infection and immune response. Can. J. Cardiol. 1996; 12: 935–43.

  34. Mahfoud F., Gartner B., Kindermann M. et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur. Heart. J. 2011; 32: 897–903.

  35. Yilmaz A., Kindermann I., Kindermann M. et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010; 122: 900–9.

  36. Kuhl U., Lassner D., von Schlippenbach J. et al. Interferon-beta improves survival in Enterovirusassociated cardiomyopathy. J. Am. Coll. Cardiol. 2012; 60: 1295–1296.

  37. Cooper L.T. Jr. Giant cell and granulomatous myocarditis. Heart Fail. Clin. 2005; 1: 431–7.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery